Mutations in DNMT3A have been reported in various hematologic malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and T-cell lymphoma and leukemia [30–34], underlining a potent tumor suppressor role. The gene discussed is DNMT3A; the disease is neoplasm.